Skip to content

4Accepted Sep 27, 4:46 PM ET

Decheng Capital China Life Sciences USD Fund III, L.P. 4

ALPNALPINE IMMUNE SCIENCES, INC.

Accepted (ET)

4:46 PM

Sep 27, 2022

Filed

Sep 27, 2022

Documents

1

Size

9.7 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.